Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 16076 - 16100 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Carmustine	Approved Investigational	ESRRA	2101	upregulated	Carmustine results in increased expression of ESRRA mRNA	11q13.1	A21555
Carmustine	Approved Investigational	EZH2	2146	downregulated	Carmustine results in decreased expression of EZH2 mRNA	7q36.1	A21555
Carmustine	Approved Investigational	FBN1	2200	downregulated	Carmustine results in decreased expression of FBN1 mRNA	15q21.1	A21555
Carmustine	Approved Investigational	FKBP1A	2280	downregulated	Carmustine results in decreased expression of FKBP1A mRNA	20p13	A21555
Carmustine	Approved Investigational	FNTA	2339	downregulated	Carmustine results in decreased expression of FNTA mRNA	8p11.21	A21555
Carmustine	Approved Investigational	FNTA	2339	upregulated	Carmustine results in increased expression of FNTA mRNA	8p11.21	A21555
Carmustine	Approved Investigational	FOXJ1	2302	downregulated	Carmustine results in decreased expression of FOXJ1 mRNA	17q25.1	A21555
Carmustine	Approved Investigational	FTH1	2495	downregulated	Carmustine results in decreased expression of FTH1 mRNA	11q12.3	A21555
Carmustine	Approved Investigational	FTL	2512	downregulated	Carmustine results in decreased expression of FTL mRNA	19q13.33	A21555
Carmustine	Approved Investigational	FYN	2534	downregulated	Carmustine results in decreased expression of FYN mRNA	6q21	A21555
Carmustine	Approved Investigational	GABRA2	2555	downregulated	Carmustine results in decreased expression of GABRA2 mRNA	4p12	A21555
Carmustine	Approved Investigational	GABRA6	2559	downregulated	Carmustine results in decreased expression of GABRA6 mRNA	5q34	A21555
Carmustine	Approved Investigational	GAMT	2593	downregulated	Carmustine results in decreased expression of GAMT mRNA	19p13.3	A21555
Carmustine	Approved Investigational	GAST	2520	downregulated	Carmustine results in decreased expression of GAST mRNA	17q21.2	A21555
Carmustine	Approved Investigational	GCM1	8521	upregulated	Carmustine results in increased expression of GCM1 mRNA	6p12.1	A21555
Carmustine	Approved Investigational	GDI1	2664	upregulated	Carmustine results in increased expression of GDI1 mRNA	Xq28	A21555
Carmustine	Approved Investigational	GDI2	2665	upregulated	Carmustine results in increased expression of GDI2 mRNA	10p15.1	A21555
Carmustine	Approved Investigational	GFAP	2670	downregulated	Carmustine results in decreased expression of GFAP mRNA	17q21.31	A21555
Carmustine	Approved Investigational	GHSR	2693	downregulated	Carmustine results in decreased expression of GHSR mRNA	3q26.31	A21555
Carmustine	Approved Investigational	GNRHR	2798	upregulated	Carmustine results in increased expression of GNRHR mRNA	4q13.2	A21555
Carmustine	Approved Investigational	GOLGA2	2801	downregulated	Carmustine results in decreased expression of GOLGA2 mRNA	9q34.11	A21555
Carmustine	Approved Investigational	GOLGA4	2803	upregulated	Carmustine results in increased expression of GOLGA4 mRNA	3p22.2	A21555
Carmustine	Approved Investigational	GP1BB	2812	downregulated	Carmustine results in decreased expression of GP1BB mRNA	22q11.21	A21555
Carmustine	Approved Investigational	GPR25	2848	downregulated	Carmustine results in decreased expression of GPR25 mRNA	1q32.1	A21555
Carmustine	Approved Investigational	GPR32	2854	downregulated	Carmustine results in decreased expression of GPR32 mRNA	19q13.33	A21555

Displaying entries 16076 - 16100 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability